Linkedin stuff, page-52

A Senior Lifesciences Executive, Board member and Advisor from Jana Care in the US liked our sepsis post and also has ADO in his interests section.

They have offices in the US and India.

"Jana Care is a global company developing biomarker assays for its proprietary digital health platform with the goal of improving health outcomes for people living with chronic diseases. Our unique approach combines low-cost diagnostics, lifestyle coaching, and predictive analytics, all delivered through a smartphone. Our products provide actionable information to both patients and health care providers. Our international team works between our offices in Boston, MA and Bangalore, India."

https://www.janacare.com/




"The signals on the test strip are read by our Aina device, an optical reader capable of reading multiple modalities (colorimetric and fluorescent). Our proprietary design of the optics is compact, affordable, and allows multiple assays to be analyzed on the same reader. The flexibility of Aina allows it to be used for tests we haven’t imagined yet."


Potential anteobind customer (unless using Europium).
Potential IP license customer
Potential manufacturing partner
Potential distributor
Potential provider of a new reader platform

Reading just the strip would bypass the need to assemble tests into casettes. That would hugely reduce costs. Ellume were doing that by hand.